Which of the following is the treatment of choice in V 600E BRAF-mutant NSCLC?

Q. Which of the following is the treatment of choice in V 600E BRAF-mutant NSCLC?

A.            Dabrafenib

B.            Dabrafenib plus vemurafenib

C.            Dabrafenib plus trametinib

D.            Dabrafenib plus ipilimumab

Answer: Dabrafenib plus trametinib